维昇药业致力于内分泌相关疾病治疗，将全球领先的治疗方法及药品引入中国，希望能够让更多的中国患者快速地接触到全球先进可靠的治疗方案。
Investors 3
| Date | Name | Website |
| 31.10.2020 | Sofinnova ... | sofinnova.... |
| - | Vivo Capit... | vivocapita... |
| - | HBM Partne... | hbmpartner... |
Mentions in press and media 2
| Date | Title | Description | Source |
| 08.03.2024 | VISEN Announces Acceptance of a Biologics License Applicatio... | SHANGHAI, March 8, 2024 /PRNewswire/ -- VISEN Pharmaceuticals (VISEN), an innovative biopharmaceutic... | en.prnasia... |
| 16.11.2023 | Once-Weekly TransCon™ CNP Achieved Primary Efficacy Objectiv... | SHANGHAI, Nov. 16, 2023 /PRNewswire/ -- VISEN Pharmaceuticals (VISEN), an innovative biopharmaceutic... | en.prnasia... |